FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve

Core Viewpoint - The U.S. Federal Trade Commission has successfully blocked Edwards Lifesciences Corp's acquisition of Jenavalve Technology Inc, as indicated by court records [1] Company Summary - Edwards Lifesciences Corp aimed to acquire Jenavalve Technology Inc, but the acquisition has been halted by a ruling from the U.S. Federal Trade Commission [1] - The ruling reflects regulatory scrutiny in the healthcare sector, particularly concerning mergers and acquisitions that may impact competition [1] Industry Summary - The decision by the Federal Trade Commission highlights ongoing regulatory challenges faced by companies in the medical technology industry regarding consolidation and market competition [1]